Plain-English translation of NCT07662135 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes Mellitus research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help people with type 2 diabetes and reduced kidney function control their blood sugar better. You would take the medication once daily as a pill, along with your current diabetes medicines including dapagliflozin. Researchers will compare how well the medication works compared to a placebo (a dummy pill with no active ingredient) and watch for any side effects.
Many people with type 2 diabetes develop kidney problems, and their kidneys become less able to filter blood sugar and waste. This medication is being tested because it may offer an additional way to help control blood sugar in people with both diabetes and weakened kidneys.
You likely qualify if…
You likely don't qualify if…
You would take a daily pill of either the new medication or a placebo for the duration of the study, along with your regular diabetes medicines. The study involves visits where researchers will check your blood sugar levels, kidney function, weight, and overall health to see how well the treatment works and whether you experience any side effects. About 900 people total will participate in this study, which is sponsored by AstraZeneca.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
United States